Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lithoplasty Technology Treats Coronary Artery Disease

By HospiMedica International staff writers
Posted on 29 May 2017
A combination of balloon angioplasty and lithotripsy breaks up calcified plaques that cause arteries to narrow and restores blood flow.

The Shockwave Medical lithoplasty system is comprised of balloon dilatation catheter with inset lithotripsy electrodes that increase the compliance of rigid vascular and valvular lesions. More...
The vascular calcium deposits are then subjected to a brief series of powerful mechanical pulses. Stressed from the induced vibrations, the plaque becomes more pliable; the integrated balloon catheter is then dilated at low pressures to expand the lesion evenly, without damaging the vessels themselves.

The pre-treatment enables more effective angioplasty, less frequent bailout stent usage, and enhanced lesion preparation, thus minimizing any potential acute soft tissue injury that could lead to the need for additional interventional treatments or long-term restenosis. The technology is currently undergoing a premarket, prospective, single-arm study in seven sites in Europe and Australia in order to evaluate the use of lithoplasty for treat calcified arteries in CAD patients before they receive a drug-eluting stent.

“Cardiovascular calcification presents a persistent treatment challenge for the interventionalist,” said Jean Fajadet, MD, of Clinique Pasteur (Toulouse, France), co-principal investigator of the international clinical trial of the technology. “The use of lithoplasty in the coronary arteries is an important new option that has shown in the clinical study of the device to effectively prepare the vessel for stent implantation with minimal complications.”

“We are a step closer to bringing lithoplasty to patients and physicians in Europe as a potentially paradigm-changing technology for the treatment of coronary artery disease,” said Doug Godshall, CEO of Shockwave Medical. “We look forward to sharing our final six-month results…and to continuing to gather clinical evidence on the benefits of this promising treatment for a challenging patient population.”

The presence of calcified CAD leads to suboptimal outcomes for all treatment options - medical therapy, interventional treatment, and cardiac surgery. For angioplasty with a stent, the presence of calcified lesions is associated with suboptimal lesion expansion, poor stent apposition, and complications that include dissection, distal embolization, coronary hypoperfusion, and procedural failure.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.